More GBL Marketers Sent Warning Letters By FDA
This article was originally published in The Tan Sheet
Executive Summary
Three companies that refuse to voluntarily products containing gamma-butyrolactone (GBL) received March 8 warning letters from FDA. The letters went to Invigorate International, Cabot Industries and Nutritional Concepts.